Table 2 Indications for amniotic membrane transplant.
| Indication | Number (%) | SE | Previous treatment duration in weeks (SD) |
|---|---|---|---|
| 1. PED | 88 (37.8)* | 3.2 | 16.7 (26.3) |
| Neurogenic: herpes zoster/simplex | 14 (15.9)† | ||
| post‐operative | 7 (8.0) | ||
| Trauma: chemical burns, artefacta | 12 (13.6) | ||
| Infection (1 with inflammation) | 11 (12.5) | ||
| Keratoconjunctivitis sicca (3 with inflammation) | 9 (10.2) | ||
| Inflammation: ocular cicatricial pemphigoid | 9 (10.2) | ||
| Stevens Johnson | 2 (2.3) | ||
| Other | 10 (11.4) | ||
| Lid anomalies (3 with inflammation or infection) | 5 (5.7) | ||
| Diabetic autonomic neuropathy | 5 (5.7) | ||
| Medicamentosa | 3 (3.4) | ||
| Epithelial basement membrane dystrophy | 1 (1.1) | ||
| 2. LSCD | 35 (15.0) | 2.3 | 34.7 (67.9) |
| Total | 21 (60.0) † | ||
| Sectoral | 10 (28.6) | ||
| Mosaic | 4 (11.4) | ||
| 3. OSR | 67 (28.8) | 3.0 | 33.1 (107.1) |
| Lesion excision (pterygium, neoplasia, other) | 19 (28.4) † | ||
| Conjunctival cicatrix | 34 (50.7) | ||
| Lesion excision and conjunctival cicatrix | 2 (3.0) | ||
| Other | 12 (17.9) | ||
| 4. CHEM | 42 (18.0) | 2.5 | 4.3 (11.2) |
| Acid | 3 (7.1) † | ||
| Alkali | 34 (81.0) | ||
| Acid and Alkali | 4 (9.5) | ||
| Thermal | 1 (2.4) | ||
| 5. BK | 42 (18.0) | 2.5 | 33.0 (63.8) |
| 6. TRAB | 2 (0.9) | 0.6 | 16.0 (5.7) |
| 7. Other | 11 (4.7) | 1.4 | 49.5 (156.1) |
| 8. Unknown | 2 (0.9) | ||
| TOTAL | 233 |
PED, persistent epithelial defect; LSCD, limbal stem cell deficiency; OSR, ocular surface reconstruction; CHEM, chemical/thermal injury; BK, bullous keratopathy, TRAB, trabeculectomy
*% of 233 procedures. Total number of indications exceeds total number of procedures due to more than one indication per procedure; †% of cases within each indication